Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05643742 |
| Title | A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | CRISPR Therapeutics AG |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | RECRUITING | Westwood | Kansas | 66205 | United States | Details |
| Research Site | RECRUITING | Saint Louis | Missouri | 63110 | United States | Details |
| Research Site | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
| Research Site | RECRUITING | Camperdown | New South Wales | 2050 | Australia | Details |
| Research Site | RECRUITING | Melbourne | Victoria | 3004 | Australia | Details |
| Research Site | RECRUITING | Nedlands | Western Australia | 6009 | Australia | Details |